Autolus Therapeutics (AUTL) Revenue (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Revenue came in at $24.3 million in Q4 2025, up 83655.17% YoY from N/an in Q4 2024, and up 14.6% on a QoQ basis from $21.2 million in Q3 2025.
Autolus Therapeutics (AUTL) Revenue (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Revenue data on file, last reported at $24.3 million in Q4 2025.
- Quarterly Revenue rose 83655.17% year-over-year to $24.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.4 million (up 644.28% YoY) and the FY2025 annual result came in at $75.4 million, up 644.94% from the prior year.
- Revenue climbed to $24.3 million in Q4 2025, from $21.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $24.3 million in Q4 2025 to a low of $29000.0 in Q4 2024.
- A 5-year average of $6.8 million and a median of $1.9 million in 2021 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue tumbled 82.86% — and 2025, when it soared 83655.17%.
- Tracing AUTL's Revenue over 5 years: stood at $236000.0 in 2021, then surged by 1450.42% to $3.7 million in 2022, then sank by 88.9% to $406000.0 in 2023, then sank by 92.86% to $29000.0 in 2024, then soared by 83655.17% to $24.3 million in 2025.
- The last three Revenue figures came in at $24.3 million (Q4 2025), $21.2 million (Q3 2025), and $20.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 45.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.69 Mn |
| Dec 31, 2025 | 24.29 Mn |
| Sep 30, 2025 | 21.19 Mn |
| Jun 30, 2025 | 20.92 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 10.10 Mn |
| Sep 30, 2023 | 406,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 166,000.00 |
| Sep 30, 2021 | 236,000.00 |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | 269,000.00 |
| Dec 31, 2020 | 404,000.00 |
| Sep 30, 2020 | 438,000.00 |
| Jun 30, 2020 | 293,000.00 |
| Mar 31, 2020 | 338,000.00 |
| Jun 30, 2019 | 2.30 Mn |